Achilles Therapeutics Plc Stock Price on November 27, 2024
| ACHL Stock | USD 1.08 0.01 0.93% |
If you're considering investing in Achilles Stock, it is important to understand the factors that can impact its price. As of today, the current price of Achilles Therapeutics stands at 1.08, as last reported on the 30th of November, with the highest price reaching 1.08 and the lowest price hitting 1.05 during the day. Achilles Therapeutics appears to be very risky, given 3 months investment horizon. Achilles Therapeutics PLC secures Sharpe Ratio (or Efficiency) of 0.17, which signifies that the company had a 0.17% return per unit of standard deviation over the last 3 months. By analyzing Achilles Therapeutics' technical indicators, you can evaluate if the expected return of 0.76% is justified by implied risk. Please makes use of Achilles Therapeutics' risk adjusted performance of 0.1275, and Mean Deviation of 1.97 to double-check if our risk estimates are consistent with your expectations.
At this time, Achilles Therapeutics' Total Stockholder Equity is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 225.1 M this year, although the value of Common Stock Total Equity will most likely fall to about 21.4 K. . The value of Price Earnings Ratio is estimated to slide to -0.54. The value of Price Book Value Ratio is estimated to slide to 0.24. Achilles Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Achilles |
Sharpe Ratio = 0.1653
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ACHL | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.58 actual daily | 40 60% of assets are more volatile |
Expected Return
| 0.76 actual daily | 15 85% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Achilles Therapeutics is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Achilles Therapeutics by adding it to a well-diversified portfolio.
Price Book 0.4263 | Book Value 3.465 | Enterprise Value -36.7 M | Enterprise Value Ebitda 1.6583 | Shares Float 20.8 M |
Related Headline
Assembly Biosciences Headline on 27th of November 2024
The Brick school board delayed a vote on a 6.2 million lease-purchase of buses over safety and cost questions. Heres a look at both.
Achilles Therapeutics Valuation on November 27, 2024
It is possible to determine the worth of Achilles Therapeutics on a given historical date. On November 27, 2024 Achilles was worth 1.05 at the beginning of the trading date compared to the closed value of 1.07. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Achilles Therapeutics stock. Still, in general, we apply an absolute valuation method to find Achilles Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Achilles Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Achilles Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 1.08 | 1.08 | 1.04 | 1.07 | 44,726 | |
11/27/2024 | 1.05 | 1.08 | 1.04 | 1.07 | 98,715 |
| 1.07 | 1.08 | 1.05 | 1.08 | 22,605 |
| Backtest Achilles Therapeutics | | | Achilles Therapeutics History | | | Achilles Therapeutics Valuation | Previous | Next |
Achilles Therapeutics Trading Date Momentum on November 27, 2024
| On November 29 2024 Achilles Therapeutics PLC was traded for 1.08 at the closing time. The top price for the day was 1.08 and the lowest listed price was 1.05 . The trading volume for the day was 22.6 K. The trading history from November 29, 2024 was a factor to the next trading day price upswing. The overall trading delta against the next closing price was 0.93% . The overall trading delta against the current closing price is 0.00% . |
Achilles Therapeutics PLC Fundamentals Correlations and Trends
By evaluating Achilles Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Achilles Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Achilles financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Achilles Therapeutics Stock history
Achilles Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Achilles is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Achilles Therapeutics PLC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Achilles Therapeutics stock prices may prove useful in developing a viable investing in Achilles Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 40 M | 33 M | |
| Net Loss | -64.1 M | -60.9 M |
Achilles Therapeutics Quarterly Net Working Capital |
|
Achilles Therapeutics Stock Technical Analysis
Achilles Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Achilles Therapeutics Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Achilles Therapeutics PLC cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Achilles Therapeutics November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Achilles Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Achilles Therapeutics shares will generate the highest return on investment. By undertsting and applying Achilles Therapeutics stock market strength indicators, traders can identify Achilles Therapeutics PLC entry and exit signals to maximize returns
Achilles Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Achilles Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Achilles Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Achilles to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1275 | |||
| Jensen Alpha | 0.5191 | |||
| Total Risk Alpha | (0.06) | |||
| Sortino Ratio | 0.2324 | |||
| Treynor Ratio | 0.5099 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Achilles Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Achilles Therapeutics. If investors know Achilles will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Achilles Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.66) | Return On Assets (0.27) | Return On Equity (0.44) |
The market value of Achilles Therapeutics PLC is measured differently than its book value, which is the value of Achilles that is recorded on the company's balance sheet. Investors also form their own opinion of Achilles Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Achilles Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Achilles Therapeutics' market value can be influenced by many factors that don't directly affect Achilles Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Achilles Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Achilles Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Achilles Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.